Pharmaceutical Technology

APRIL 5, 2023

Absci has collaborated with bioinformatics firm M2GEN to expedite the development of new cancer medicines. Absci stated that this collaboration combines AI drug creation technology and oncology bioinformatics, thereby reducing the time and cost of cancer drug development.

Development 130

Development Bioinformatics Drugs Immune Response 130

Scienmag

SEPTEMBER 24, 2020

DrBioRight uses natural-language interface to facilitate intuitive data analysis for broader research community Credit: The University of Texas MD Anderson Cancer Center HOUSTON — A new data analysis tool developed by researchers at The University of Texas MD Anderson Cancer Center incorporates a user-friendly, natural-language interface to allow (..)

Bioinformatics 48

Bioinformatics Big Data Research Development 48

Pharmaceutical Technology

JUNE 28, 2022

Researchers at the Rensselaer Polytechnic Institute in the US have received a five-year, $3.5m The latest research is part of the consortium of a new antiviral drug development centre named Center for Antiviral Medicines and Pandemic Preparedness (CAMPP), to be led by Scripps Research.

Development 147

Development Bioinformatics Drugs Allergies 147

Pharmaceutical Technology

FEBRUARY 17, 2023

Oncology-focused bioinformatics firm M2GEN has entered a multi-year strategic collaboration with Zephyr AI to identify treatments and cures for cancer patients. This partnership not only holds the potential to chart a new era of drug discovery and precision medicine but to save innumerable lives.”

Bioinformatics 147

Bioinformatics Production Clinical Trials Clinical Trials 147

pharmaphorum

JULY 20, 2022

Cancer Research UK has expanded an alliance with investment group Deep Science Ventures with a commitment to support the formation up to 10 new oncology startups. The post Cancer Research UK partnership aims to back 10 new startups appeared first on.

Research 83

Research Bioinformatics Gene Therapy Medicine 83

Medical Xpress

NOVEMBER 8, 2022

A team of researchers at Indiana University School of Medicine has developed specialized bioinformatics software designed to identify rare genetic variants in whole-genome sequencing studies. Zilin Li, Ph.D.,

Genetics 75

Genetics Bioinformatics Genome Genomics 75

Drug Discovery World

FEBRUARY 17, 2023

The drug discovery sector is feeling the love this Valentine’s week, with several new research collaborations bringing together a range of expertise and advanced bioinformatics, automation and artificial intelligence technologies to speed up the development of new treatments.

Bioinformatics 52

Bioinformatics Drugs Genome Genomics 52

Drug Discovery World

SEPTEMBER 29, 2023

AI-driven drug discovery company Insilico Medicine and the University of Cambridge have discovered an approach to identify therapeutic targets for human diseases associated with protein phase separation (PPS). Recent research has demonstrated that PPS is widely present in cells and drives a variety of important biological functions.

Protein 69

Protein Bioinformatics Medicine Engineer 69

Scienmag

JANUARY 27, 2021

New research from the University of Illinois says yes. In a paper published in Evolutionary Bioinformatics, Illinois researchers show COVID-19 cases and mortality rates, among other […]. . – With cities around the globe locking down yet again amid soaring COVID-19 numbers, could seasonality be partially to blame?

Bioinformatics 95

Bioinformatics Research Genetics Medicine 95

pharmaphorum

SEPTEMBER 16, 2022

Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research collaboration with Sosei Heptares. Kim recognised then, he said, that better tools for medicine needed to be developed, and that they still do.

Development 122

Development Research Drugs Clinical Trials 122

Drug Discovery World

FEBRUARY 17, 2023

A new multi-year strategic partnership between M2GEN and Zephyr AI will leverage clinicogenomic data, bioinformatics, and artificial intelligence to accelerate drug discovery and expanded use cases for oncology treatments. million lives around the world,” said Grant Verstandig, Co-Founder and Executive Chairman of Zephyr AI.

Bioinformatics 52

Bioinformatics Drugs Licensing Licensing 52

Scienmag

JULY 16, 2021

Credit: Vaughn Cooper PITTSBURGH, July 16, 2021 – For the first time ever, researchers from the University of Pittsburgh School of Medicine discovered that phages–tiny viruses that attack bacteria–are key to initiating rapid bacterial evolution leading to the emergence of treatment-resistant “superbugs.”

Research 73

Research Bacteria Medicine Bioinformatics 73

Scienmag

FEBRUARY 8, 2021

Researchers at Uppsala University have tested the bioinformatic predictions made by another research group and have identified receptors that could be important players in the process. The molecular details of how SARS-CoV-2 enters cells and infects them are still not clear.

Bioinformatics 75

Bioinformatics Research Allergies Medicine 75

Rethinking Clinical Trials

FEBRUARY 28, 2024

            Speakers Adrian Hernandez, MD Executive Director, Duke Clinical Research Institute Vice Dean, Duke University School of Medicine Christopher J. Solutions include a bi-directional EDC (electronic data capture system), MyChart for research, and active notifications to study personnel based on entered data.

Clinical Trials 141

Clinical Trials Clinical Trials Trials Clinical Research 141

Scienmag

NOVEMBER 12, 2020

In a study that has unprecedented implications to advance both medicine and biodiversity conservation, researchers have sequenced 131 new placental mammal genomes, bringing the worldwide total to more than 250 In a study that has unprecedented implications to advance both medicine and biodiversity conservation, researchers have sequenced 131 new placental (..)

Biobanking 41

Biobanking Medicine Genome Genomics 41

Scienmag

FEBRUARY 10, 2021

Data demonstrates new increased diversity in genetic studies and provides new insights into population-specific diseases Researchers at the University of Maryland School of Medicine (UMSOM) and their colleagues published a new analysis today in the journal Nature from genetic sequencing data of more than 53,000 individuals, primarily from minority (..)

Genetics 71

Genetics Research Medicine Bioinformatics 71

Scienmag

SEPTEMBER 7, 2020

Credit: Felix Petermann, MDC Hundreds of innovators, research pioneers, clinicians, industry leaders and policy makers from all around Europe are united by a vision of how to revolutionize healthcare.

Medicine 58

Medicine Research Bioinformatics Allergies 58

pharmaphorum

MARCH 19, 2021

As data and digital technology become vital to every aspect of life sciences, the industry is increasingly looking beyond biologists, chemists, and doctors to drive its drug development – and finding that technology has a chief role to play in the future of medicine. According to an article by Stephens, Zachary D.,

Bioinformatics 57

Bioinformatics Drugs Genome Genomics 57

Drug Discovery World

DECEMBER 7, 2023

A cross-sector working group of MND experts was convened by MND Association and My Name’5 Doddie Foundation and coordinated by Medicines Discovery Catapult throughout 2022. The group examined barriers to translating basic science into effective therapies for MND and suggested guiding principles for future research.

Drugs 52

Drugs Bioinformatics Clinical Trials Clinical Trials 52

Drug Discovery World

MAY 16, 2023

The company’s DNA-based platform is being developed to address manufacturing challenges associated with the production of recombinant adeno-associated virus (rAAV) vectors used to produce advanced therapy medicinal products (ATMPs).

Production 52

Production Gene Therapy Gene Bioinformatics 52

The Pharma Data

JANUARY 24, 2021

Professor of Medicine, Section of Infectious Diseases and Global Health and director of the Duchossois Family Institute at the University of Chicago, has joined its scientific advisory board. His research focuses on the role of the microbiome in immune defense and disease resistance. Diversigen, Inc.

Research 40

Research Bioinformatics Scientist Medicine 40

Scienmag

SEPTEMBER 22, 2020

Credit: Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai Bottom Line: Given the toll that the COVID-19 pandemic has taken on people’s health and lives worldwide, it is crucial to be able to accurately predict patients’ outcomes, including their chances of mortality from the disease.

Development 52

Development Genome Genomics Research 52

Drug Discovery World

NOVEMBER 17, 2022

Researchers have identified 35 genes associated with long-term Lyme disease that could potentially be used as biomarkers to diagnose patients with the condition. . The findings, from the Icahn School of Medicine at Mount Sinai in New York and published in the journal Cell Reports Medicine , may also lead to new therapeutic targets.

Genetics 52

Genetics RNA Immune Response Bioinformatics 52

Scienmag

APRIL 12, 2021

The researchers will use the approaches they develop to identify clues about how mental illness presents in the brain ATLANTA–Georgia State University researchers have received a five-year, $3 million grant from the National Institute of Mental Health to develop new strategies to identify mood disorders using whole brain dynamics, which considers (..)

Research 71

Research Development Bioinformatics Engineer 71

Drug Discovery World

NOVEMBER 30, 2023

Kimryn Rathmell has been chosen as the 17 th director of the National Cancer Institute (NCI), bringing her experience as leader of the Department of Medicine at the Vanderbilt University Medical Center and Physician-in-Chief at the Vanderbilt University Adult Hospital and Clinics.

Drugs 52

Drugs Genome Genomics Bioinformatics 52

Scienmag

JULY 12, 2021

USC researchers have achieved a better way to identify elusive DNA variants responsible for genetic changes affecting cell functions and diseases. Using computational biology tools, scientists at the university’s Dornsife College of Letters, Arts and Sciences studied “variable-number tandem repeats” (VNTR) in DNA.

DNA 69

DNA Research Genetics Scientist 69

Drug Discovery World

NOVEMBER 7, 2022

A new study led by Medical Research Council-funded researchers from UCL has found that tailoring the analysis of whole genome sequencing to individual patients could double the diagnostic rates of rare diseases. . Context . It also detected potential disease-causing variants in a further 3.9% of patients. . Official comments .

Genome 52

Genome Genomics Genetics Genetic Disease 52

Scienmag

SEPTEMBER 4, 2020

Jonek The European Research Council (ERC) has awarded ERC Starting Grants to two researchers from Bielefeld University. million euros for top-level research in their disciplines. ERC Starting Grants for Professor Dr Martina Hofmanová and Dr Toni Goßmann Credit: Photo: Bielefeld University /S. They will each receive 1.5

Research 56

Research Bioinformatics Gene Genetics 56

pharmaphorum

JULY 5, 2022

Cell therapy specialist Mogrify has struck a deal with Japanese drugmaker Astellas to look at ways to deploy regenerative medicine to treat hearing loss caused by factors such as chronic exposure to loud noises.

In-Vivo 89

In-Vivo Bioinformatics Genetics Licensing 89

Drug Discovery World

APRIL 18, 2023

DDW’s Megan Thomas rounds up highlights from Tuesday 17 April at AACR 2023, from AI and mathematical oncology to winners of the AACR James S Ewing-Thelma B Dunn Award for Outstanding Achievement in Pathology in Cancer Research. Dunn Award for Outstanding Achievement in Pathology in Cancer Research Another award highlight was the AACR James S.

Genetics 52

Genetics DNA Research Bioinformatics 52

Drug Discovery World

MAY 1, 2024

The company also partnered with a top 20 pharma company and has been successful in identifying antibody candidates for a target of interest, with greater diversity (2.3x) and accuracy compared to alternative bioinformatics pipeline selection methods.

Antibody 59

Antibody FDA Approval Drugs Development 59

pharmaphorum

MAY 27, 2022

This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials. data processing systems that support bioinformatics modelling) and digital record systems (e.g. You can read part one of this article here. What comes next?

Clinical Trials 78

Clinical Trials Clinical Trials Trials Packaging 78

Drug Discovery World

DECEMBER 26, 2023

Donidalorsen is an investigational ligand-conjugated antisense (LICA) medicine designed to target the prekallikrein, or PKK, pathway. We are excited to collaborate with Otsuka given their proven results in bringing rare disease medicines to patients in Europe,” said Brett Monia, Ionis Chief Executive Officer.

Drugs 52

Drugs Development Medicine Bioinformatics 52

Scienmag

SEPTEMBER 22, 2020

Credit: CDC Researchers around the world are a step closer to a better understanding of the intricacies of COVID-19 thanks to two new web resources developed by investigators at Baylor College of Medicine and the University of California San Diego.

Medicine 78

Medicine Development Research Bioinformatics 78

Drug Discovery World

OCTOBER 20, 2023

The acquisition of Olink underscores the profound impact that proteomics is having as our customers continue to advance life science research and precision medicine,” said Marc Casper, Chairman, President and Chief Executive Officer of Thermo Fisher.

Drugs 52

Drugs Antibody DNA Gene Therapy 52

Scienmag

JANUARY 13, 2021

To discover these associations, researchers need to compare the genomes of many individuals at millions of genetic locations or markers, and therefore require cost-effective genotyping technologies. A new statistical method, developed […].

Genome 57

Genome Genomics Genotype Genetics 57

Scienmag

DECEMBER 21, 2020

Researchers from OSU’s Geospatial Ecology of Marine Megafauna Laboratory collected 158 fecal, commonly known as poop, samples from Eastern North […].

Hormones 52

Hormones Research Bioinformatics Medicine 52